UniProt ID | LYAM1_HUMAN | |
---|---|---|
UniProt AC | P14151 | |
Protein Name | L-selectin | |
Gene Name | SELL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 372 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . |
|
Protein Description | Calcium-dependent lectin that mediates cell adhesion by binding to glycoproteins on neighboring cells. [PubMed: 12403782] | |
Protein Sequence | MIFPWKCQSTQRDLWNIFKLWGWTMLCCDFLAHHGTDCWTYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIRKIGGIWTWVGTNKSLTEEAENWGDGEPNNKKNKEDCVEIYIKRNKDAGKWNDDACHKLKAALCYTASCQPWSCSGHGECVEIINNYTCNCDVGYYGPQCQFVIQCEPLEAPELGTMDCTHPLGNFSFSSQCAFSCSEGTNLTGIEETTCGPFGNWSSPEPTCQVIQCEPLSAPDLGIMNCSHPLASFSFTSACTFICSEGTELIGKKKTICESSGIWSNPSPICQKLDKSFSMIKEGDYNPLFIPVAVMVTAFSGLAFIIWLARRLKKGKKSKRSMNDPY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
60 | N-linked_Glycosylation | ARRFCRDNYTDLVAI HHHHHHCCHHHEEEE | 23.42 | 28011641 | |
73 | N-linked_Glycosylation | AIQNKAEIEYLEKTL EECCHHHHHHHHHHC | 5.15 | 16335952 | |
78 | Ubiquitination | AEIEYLEKTLPFSRS HHHHHHHHHCCCCCC | 53.41 | - | |
79 | Phosphorylation | EIEYLEKTLPFSRSY HHHHHHHHCCCCCCE | 30.23 | 23882029 | |
91 | Ubiquitination | RSYYWIGIRKIGGIW CCEEEEEEEEECCEE | 2.74 | - | |
91 (in isoform 2) | Ubiquitination | - | 2.74 | - | |
93 | Ubiquitination | YYWIGIRKIGGIWTW EEEEEEEEECCEEEE | 43.72 | - | |
104 | N-linked_Glycosylation | IWTWVGTNKSLTEEA EEEECCCCHHHHHHH | 26.45 | 28011641 | |
105 | Ubiquitination | WTWVGTNKSLTEEAE EEECCCCHHHHHHHH | 46.83 | - | |
106 | Ubiquitination | TWVGTNKSLTEEAEN EECCCCHHHHHHHHH | 42.46 | - | |
106 (in isoform 2) | Ubiquitination | - | 42.46 | - | |
117 | N-linked_Glycosylation | EAENWGDGEPNNKKN HHHHCCCCCCCCCCC | 48.61 | 28489325 | |
118 (in isoform 2) | Ubiquitination | - | 49.98 | - | |
118 | Ubiquitination | AENWGDGEPNNKKNK HHHCCCCCCCCCCCH | 49.98 | - | |
122 | Ubiquitination | GDGEPNNKKNKEDCV CCCCCCCCCCHHHHE | 65.45 | - | |
123 | Ubiquitination | DGEPNNKKNKEDCVE CCCCCCCCCHHHHEE | 75.32 | - | |
125 | Ubiquitination | EPNNKKNKEDCVEIY CCCCCCCHHHHEEEE | 64.90 | - | |
132 | Phosphorylation | KEDCVEIYIKRNKDA HHHHEEEEEECCCCC | 6.20 | - | |
134 | Ubiquitination | DCVEIYIKRNKDAGK HHEEEEEECCCCCCC | 32.71 | - | |
135 | Ubiquitination | CVEIYIKRNKDAGKW HEEEEEECCCCCCCC | 45.96 | 22505724 | |
136 (in isoform 2) | Ubiquitination | - | 41.37 | - | |
137 | Ubiquitination | EIYIKRNKDAGKWND EEEEECCCCCCCCCH | 53.65 | - | |
138 | Ubiquitination | IYIKRNKDAGKWNDD EEEECCCCCCCCCHH | 65.19 | - | |
138 (in isoform 2) | Ubiquitination | - | 65.19 | - | |
141 | Ubiquitination | KRNKDAGKWNDDACH ECCCCCCCCCHHHHH | 44.54 | - | |
147 | Ubiquitination | GKWNDDACHKLKAAL CCCCHHHHHHHHHHH | 3.60 | - | |
147 (in isoform 2) | Ubiquitination | - | 3.60 | - | |
149 | Ubiquitination | WNDDACHKLKAALCY CCHHHHHHHHHHHHE | 52.12 | - | |
150 (in isoform 2) | Ubiquitination | - | 1.71 | - | |
150 | Ubiquitination | NDDACHKLKAALCYT CHHHHHHHHHHHHEE | 1.71 | - | |
154 | Ubiquitination | CHKLKAALCYTASCQ HHHHHHHHHEECCCC | 2.47 | - | |
154 (in isoform 2) | Ubiquitination | - | 2.47 | - | |
162 (in isoform 2) | Ubiquitination | - | 29.31 | - | |
162 | Ubiquitination | CYTASCQPWSCSGHG HEECCCCCCCCCCCC | 29.31 | - | |
177 | N-linked_Glycosylation | ECVEIINNYTCNCDV CEEEEECCEECCCCC | 24.07 | 28489325 | |
232 | N-linked_Glycosylation | FSCSEGTNLTGIEET EECCCCCCCCCCEEE | 46.60 | UniProtKB CARBOHYD | |
246 | N-linked_Glycosylation | TTCGPFGNWSSPEPT EECCCCCCCCCCCCE | 35.52 | UniProtKB CARBOHYD | |
271 | N-linked_Glycosylation | APDLGIMNCSHPLAS CCCCEECCCCCCCCC | 23.40 | UniProtKB CARBOHYD | |
299 | Ubiquitination | GTELIGKKKTICESS CCEEECCCCEEECCC | 50.35 | - | |
300 | Ubiquitination | TELIGKKKTICESSG CEEECCCCEEECCCC | 46.75 | - | |
311 | N-linked_Glycosylation | ESSGIWSNPSPICQK CCCCCCCCCCHHHHH | 26.52 | UniProtKB CARBOHYD | |
312 (in isoform 2) | Ubiquitination | - | 35.65 | - | |
313 (in isoform 2) | Ubiquitination | - | 31.02 | - | |
313 | Ubiquitination | SGIWSNPSPICQKLD CCCCCCCCHHHHHHH | 31.02 | - | |
321 | Ubiquitination | PICQKLDKSFSMIKE HHHHHHHHHHHCCCC | 64.93 | - | |
324 | Phosphorylation | QKLDKSFSMIKEGDY HHHHHHHHCCCCCCC | 27.04 | 25907765 | |
331 | Ubiquitination | SMIKEGDYNPLFIPV HCCCCCCCCCCHHHH | 29.54 | - | |
334 (in isoform 2) | Ubiquitination | - | 5.60 | - | |
334 | Ubiquitination | KEGDYNPLFIPVAVM CCCCCCCCHHHHHHH | 5.60 | - | |
364 | Phosphorylation | RLKKGKKSKRSMNDP HHHCCCCHHCCCCCC | 36.47 | - | |
367 | Phosphorylation | KGKKSKRSMNDPY-- CCCCHHCCCCCCC-- | 26.19 | - | |
377 | Phosphorylation | DPY------------ CCC------------ | - | ||
380 | Phosphorylation | --------------- --------------- | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
372 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LYAM1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LYAM1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MUCEN_HUMAN | EMCN | physical | 15249540 | |
PODXL_HUMAN | PODXL | physical | 9625756 | |
CFAH_HUMAN | CFH | physical | 10377245 | |
GRB2_HUMAN | GRB2 | physical | 8986819 | |
MUC7_HUMAN | MUC7 | physical | 9538010 | |
CSPG2_HUMAN | VCAN | physical | 10950950 | |
MOES_HUMAN | MSN | physical | 11706008 | |
EZRI_HUMAN | EZR | physical | 11706008 | |
LYAM2_HUMAN | SELE | physical | 9024699 | |
KPCA_HUMAN | PRKCA | physical | 15192100 | |
KPCT_HUMAN | PRKCQ | physical | 15192100 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-60 AND ASN-104, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-60, AND MASS SPECTROMETRY. |